State Of New Jersey Common Pension Fund D Rigel Pharmaceuticals Inc Transaction History

State Of New Jersey Common Pension Fund D

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2019 Oct 23, 2019	SELL	$1.63 - $2.62 $1.39 Million - $2.23 Million	-850,000 Closed	0 $0
Q3 2017 Oct 25, 2017	BUY	$2.18 - $2.57 $1.85 Million - $2.18 Million	850,000	850,000 $2.16 Million

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $4.77B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.